Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (2): 277-279    DOI: 10.12891/ceog4780.2019
Original Research Previous articles | Next articles
Influence of route of delivery on perinatal outcomes in fetuses with myelomeningocele
N. Yachida1, M. Itsukaichi1, K. Haino1, T. Usuda2, J. Yoshimura3, T. Enomoto1, M. Yamaguchi1, K. Takakuwa1, *()
1Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
2Department of Pediatrics, Niigata University School of Medicine, Niigata, Japan
3Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
Download:  PDF(186KB)  ( 34 ) Full text   ( 3 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

The optimal route of delivery of fetuses with myelomeningocele is controversial. The aim of this study is to determine whether route of delivery predisposes to perinatal complications and influences short-term outcomes in patients with myelomeningocele. The authors performed a retrospective review of the medical records of 26 patients with myelomeningocele admitted to the Neonatal Intensive Care Unit in this hospital from 2001 to 2015. They compared perinatal complications and short-term outcomes of elective cesarean section (n = 21) and vaginal delivery (n = 5) groups. There were no ruptured nor infectious myelomeningoceles cases in either group. No statistically significant difference in ambulation status at two years of age was observed between the two groups. The present data suggest that perinatal complications and short-term outcomes were not associated with route of delivery. Vaginal delivery might be the optimal route of delivery for fetal myelomeningocele if there is no obstetric contraindication.

Key words:  Cesarean section      Infection      Myelomeningocele      Rupture      Vaginal delivery      Ambulation     
Published:  10 April 2019     
*Corresponding Author(s):  K. TAKAKUWA     E-mail:  obgy@med.niigata-u.ac.jp

Cite this article: 

N. Yachida, M. Itsukaichi, K. Haino, T. Usuda, J. Yoshimura, T. Enomoto, M. Yamaguchi, K. Takakuwa. Influence of route of delivery on perinatal outcomes in fetuses with myelomeningocele. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 277-279.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4780.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I2/277

[1] H. Takahashi, Y. Baba, R. Usui, S. Nagayama, K. Horie, A. Ohkuchi, S. Matsubara. Proteinuria as a novel risk factor for allogeneic blood transfusion irrespective of single or twin pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 709-713.
[2] X.Y. Zhou, K.X. Li, X.M. Shu. Analysis and discussion of high-risk factors in nine cases of uterine scar combined with complete uterine rupture[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 769-773.
[3] D. Lu, X. Bao, Q. Wang. Increasd mRNA expression of TRAF-6 and MST-4 in the placenta of women with preterm premature rupture of membranes with histological chorioamnionitis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 749-754.
[4] H.M. Kim, Y.J. Chin, H.H. Cha, W.J. Seong, M.J. Kim. Placenta accreta and uterine rupture of unscarred uterus in patients with systemic lupus erythematosus with prolonged steroid exposure: a report of two cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 785-788.
[5] A.M. Sindiani, H.M. Rawashdeh, E.H. Alshdaifat, O.F. Altal, H. Yaseen, A.A. Alhowary. The association between repeated doses of vaginal PGE2 (Dinoprostone, Prostin®) and both maternal and neonatal outcomes among women in the north of Jordan[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 329-334.
[6] J. W. Kim, Y. H. Kim, J. H. Moon, H. A. Jung, E. J. Noh. The efficacy of third-generation cephalosporin plus metronidazole versus third-generation cephalosporin plus clarithromycin in neonatal outcomes and oxidative stress markers in women with preterm premature rupture of membranes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 194-198.
[7] T. Cengiz, T. Toka Özer, F. Kılınç, R. Selimoğlu, H. Yılmaz. Candida albicans infection of cervix and comparison of Pap smear and culture in diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 253-256.
[8] R. Dias Nunes, E. Traebert, M. Seemann, J. Traebert. Evaluation of simple and low-cost diagnostic tests for premature rupture of membranes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 287-290.
[9] K. Sandal, I. Yetimoglu, M. A. Sargin, N. Tug. Ruptured myometrial tumors as a cause of spontaneous hemoperitoneum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 303-305.
[10] H. J. Wang, Y. H. Wu, P. S. Huang. Severe pelvic actinomycosis with intrauterine device in situ and abdominal wall involvement treated with medication only: case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 306-308.
[11] Grażyna Jarząbek-Bielecka, Małgorzata Mizgier, Jacek Boroch, Magdalena Pisarska-Krawczyk, Mariola Pawlaczyk, Ewa Jakubek, Witold Kędzia. Patient suffering from lichen sclerosus together with partial labial fusion (adhesion) and inflammatory infection of the vulva, vagina and anal area[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 315-319.
[12] J. Huang, Z. Zhang. Spontaneous umbilical cord vascular rupture before labor for congenital defects with a live birth: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 142-143.
[13] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[14] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[15] H. Kiyak, L. S. Turkgeldi, C. Ozdemir, S. Gunkaya, K. Tolga, A. Gedikbası. Myomectomy during cesarean section: is it a redundant or a feasible procedure?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 881-887.
No Suggested Reading articles found!